Exploring Rapamycin, Longevity and Healthspan with Dr. Matt Kaeberlein
Thumbnail from YouTube. Playing loads the YouTube player.
History & recommendationsOff
Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.
Open saved items & history →About this video
Creator description · original textText language: English
In this episode, Dr. Matt Kaeberlein, CEO of OptiSpan and co-director of the Dog Aging Project, and Joe explore the fascinating realm of rapamycin and its implications for longevity and healthspan.
Dr. Kaeberlein delves into the biological mechanisms underlying rapamycin's effects, the best way to take it, and its impact on immune system processes.
Gain insights from Dr. Kaeberlein's research on the mTor mechanism and rapamycin, uncovering their promising potential in extending healthspan and enhancing lifespan.
Finally, Matt and Joe discuss aging clocks, biomarkers, and microbiome tests, evaluating their significance in the context of aging research and longevity enhancement.
---------------
*Socials & Websites:*
• SelfDecode: https://rb.gy/eldv3z
• The Joe Cohen Show: https://thejoecohenshow.com/
• Instagram: https://www.instagram.com/mrbiohacker/
• TikTok: https://www.tiktok.com/@thejoecohenshow
• Twitter: https://twitter.com/thejoecohenshow
*Dr. Matt Kaeberlein:*
• Website: https://www.optispan.life/
---------------
*Timestamps:*
(0:00) - Intro
(02:24) - Rapamycin overview
(22:04) - How Matt uses Rapamycin
(33:24) - Biomarkers affected by rapamycin
(37:33) - Microbiome and aging clocks
(01:04:07) - How much can you maximize lifespan
The Joe Cohen Show · 64 min · Source published: 2024-02-09
Added to Harbor: 10/23/2026
Original on YouTube ↗Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.